Edward O. List
Carries out mouse studies, in John Kopchick's group, on how disrupting growth hormone receptor signaling extends mammalian lifespan
Research Associate Professor of Biomedical Sciences, Ohio University Heritage College of Osteopathic Medicine · Associate Investigator, Institute for Molecular Medicine and Aging · PhD, Ohio University
Institute for Molecular Medicine and Aging, Ohio University Heritage College of Osteopathic Medicine (Athens, Ohio, USA) ↗ ORCID0000-0002-8230-6331 ↗
Portrait: Ohio University
List is lead author of LIST2026, which showed GH-receptor-antagonist mice lived significantly longer, and co-author of DUR2026, showing adult-onset GH receptor deletion still extends healthy lifespan.
With a PhD from Ohio University, List has spent his career inside the GH/longevity mouse-model pipeline alongside Kopchick and Berryman, co-authoring dozens of core GHRKO papers.
He is a Research Associate Professor at the renamed Institute for Molecular Medicine and Aging.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | A | Growth Hormone Receptor Antagonism Extends Lifespan LIST2026 As lead author, demonstrates transgenic GH receptor antagonist significantly extends median and maximal mouse lifespan. |
| 2026 | A | Midlife Growth Hormone Receptor Ablation Extends Healthy Lifespan and Induces Sex-Specific Hepatic Transcriptional Changes at Single-Cell Resolution DUR2026 Co-authors the finding that adult-onset GH receptor ablation extends healthy lifespan and improves insulin sensitivity. |
Co-authors in the Atlas 4
People with a profile here who share at least one study with Edward O. List.
ShowHide
- Darlene E. Berryman 2 shared studies Showed that growth hormone reshapes fat tissue in a depot-specific way that links body composition to metabolic aging
- John J. Kopchick 2 shared studies Discovered the growth hormone receptor antagonist that became the acromegaly drug pegvisomant (Somavert), and studies how blocking growth hormone signalling extends lifespan in mice
- Silvana Duran-Ortiz Researcher in John Kopchick's group at Ohio University who studies how switching off growth hormone action, even in middle age, lengthens life in mice
- Yuji Ikeno Pathologist at the Barshop Institute for Longevity and Aging Studies in San Antonio whose examinations of tissues from aged mice help ageing studies tell whether an intervention changes disease, especially cancer, late in life
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.